Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for November 2013

MicroPharm Secures Biomedical Catalyst Grant

MicroPharm Limited (“MicroPharm”) announced that it has secured a grant of £0.8M to further support the development of PolyCAb.  This is part of a grant totalling £2.1M from the UK’s innovation agency, the Technology Strategy Board, to a consortium led by MicroPharm comprising Public Health England (“PHE”) and University of Leeds.

Read the full story

Posted on: Friday, 29th November 2013